Early Biodegradable Stent Placement for Percutaneous Hepaticojejunostomy Stricture Management

Percutaneous hepaticojejunostomy (HJ) stricture dilatation is associated with significant patient discomfort.1 There is also a higher rate of cholangitis and restenosis, with lower patient compliance. Biodegradable biliary stents (BDS) to treat benign biliary strictures is a recent innovation.2 BDS comprises polydioxanone material that degrades in 3–6 months via hydrolysis. BDS provides the beneficial effects of stenting without needing subsequent removal.2 BDS in HJ stricture management is a promising strategy.